Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.
about
New treatments for metastatic melanomaDysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor ImmunityRole of Tregs in Cancer Dormancy or Recurrence.gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanomaCD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination.Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors.Tumor site immune markers associated with risk for subsequent basal cell carcinomasRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage.Immune surveillance of tumors.Dendritic cells: making progress with tumour regression?'The nodule that disappeared' spontaneous regression of an eyelid noduloulcerative lesion mimicking the features of a basal cell carcinomaThe role of p53 in the immunobiology of cutaneous squamous cell carcinoma.Chronic stress and susceptibility to skin cancer.Immune response modifiers--mode of action.Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes.The anticancer immune response: indispensable for therapeutic success?Gene expression signature for spontaneous cancer regression in melanoma pigsHuman squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cellsInflammatory doses of UV may not be necessary for skin carcinogenesis.Soluble interleukin-2 receptor α and interleukin-2 serum levels in patients with basal cell carcinomaThe prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma.The tumor microenvironment: part 1.Targeting the tumor microenvironment by immunotherapy: part 2.Presentation, Treatment, and Prognosis of Secondary Melanoma within the Orbit.Characterization of three newly established rat sarcoma cell clones.DNAzyme targeting c-jun suppresses skin cancer growth.Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma.Complete spontaneous regression of a basal cell carcinoma.Cytokine profiles in spontaneously regressing basal cell carcinomas.Imiquimod 5% cream: a new treatment option for basal cell carcinoma.Oncogenes in immune cells as potential therapeutic targets.Contralateral orbital melanoma 28 years following enucleation for choroidal melanoma.
P2860
Q27007068-01CFCF2D-E4D3-45B7-A90A-4D65D3C89CDDQ28075996-EE7B32EF-3D5F-41C3-BB38-FB0AC468D536Q30244203-4AFDC1A5-63EA-4D05-A32B-E9322582CC28Q30438648-844DF7CB-4AA0-45C7-B57B-C0CEEE9AFDBEQ33840446-F2CB80CB-EB91-4D2E-B3C0-84A176CAF8FBQ33943864-82558D5E-DD05-4377-87D4-396ACBB234AFQ33958457-F1B57DB1-0E68-4671-9EBF-118F0161D092Q34042944-29D22D1D-1331-4370-8A18-D6971248A4FCQ34084756-64B6D8AB-6D1B-474F-9182-CDBE3EC787E5Q34256122-6B7F0674-B74F-4385-985A-2ED0DD6B8AB5Q34396026-832F0709-5E56-4335-8439-ACC438BE8884Q34579196-1E49933C-9053-46CA-B706-9FFEC2C6ACAEQ34983449-8B5D8AF9-D3F5-4602-A50A-C03CA9F719F4Q35065436-F5F18023-74A2-4AB2-A815-6AA066A44CDAQ35142669-369DBF97-841B-4460-8E0B-7268069F845EQ36174817-16759D91-EA14-4403-B521-C5B7F1DA28D7Q36455993-D0445E31-3033-457F-9EFF-6AAF631D4A18Q36623326-D6E0C79D-5481-4086-9DC4-9154C47F6AB2Q36677608-5B5D096B-EE36-4132-B06F-53382AA77459Q36730956-CD56D10B-A881-44AB-A603-C353EF9DF8F7Q36916400-59E56B0A-B5AA-4E0F-9AE0-042CC983A9F7Q37114132-ED0036CF-34CF-4062-B78F-371757D789C7Q37215888-4B4A8512-8676-4DAC-B123-B57025F89B88Q37395913-0B39C92D-946B-424C-8E2A-16775464B8D2Q37457078-9536880A-C0DD-40E1-81C8-B94A1B5A052BQ37952794-9CCA6232-D445-4D86-8457-7341D112D890Q37952796-E53566DA-8779-46E2-A6D6-97992EE724DBQ38687191-9CCFD50C-12B7-41BA-B031-CA34E1BA9C39Q39245288-66EEBEDA-BB68-45C6-937F-771EFF6C7D48Q39326899-C3E4B1C1-39F2-4603-BA44-9B5A9D70721FQ40327246-4DD02AC2-7C81-4A9F-8944-99871491B853Q42438384-84EFC904-35F3-4199-A384-3BAFDAF82AF4Q42490257-AB2567C9-7CDE-4267-8F93-4882EBA29DAAQ42522970-A5019B7D-72C6-47E4-9368-9C765D8C6761Q52716894-35842774-A965-4CDE-B3BB-D960B1D9BC96Q53445423-3326F848-BA6B-454B-BA64-14CF704AB309
P2860
Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@en
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@nl
type
label
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@en
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@nl
prefLabel
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@en
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@nl
P2093
P356
P1476
Spontaneous regression of huma ...... ith infiltrating CD4+ T cells.
@en
P2093
F J Tefany
G M Halliday
R S Barnetson
P2888
P304
P356
10.1007/BF00299157
P577
1995-05-01T00:00:00Z
P6179
1002377626